Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Cyclosporine A for BOS after allo-HSCT
NCT04107675Phase 2Terminated
- Sponsor
- Zambon
- Start
- Feb 2020
- Primary completion
- Jun 2022
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of liposomal cyclosporine A in Bronchiolitis Obliterans Syndrome (BOS), sponsored by Zambon. Started Feb 2020; status: terminated.
02
Drugs
liposomal cyclosporine A
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT04107675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04107675.